Frederick Florin | AFP | Getty Images

An employee works on the production of insulin pens at the factory of the US pharmaceutical company Eli Lilly in Fegersheim, France.

Pharmaceutical stocks are trading at one of their largest discounts to the market in nearly 10 years, J.P. Morgan told clients Monday.

“This underperformance reflects ongoing drug pricing concerns, many of which are either well reflected in estimates or unlikely to come to fruition for the foreseeable future,” analyst Chris Schott wrote. “We see an attractive opportunity to revisit an admittedly out-of-favor sector with a mix of new launch driven sales/earnings upside and capital deployment/M&A representing potential catalysts for the space.”

Source link

Products You May Like

Articles You May Like

Credit scores could jump 30 points this month
GOP senators weigh plan to raid Social Security for paid family leave
Trump moves to cancel student loan debt for disabled veterans
World economy is still good, but recession risks are increasing
Health-care costs in retirement grow to $280K

Leave a Reply

Your email address will not be published. Required fields are marked *